Completed PHASE2 INTERVENTIONAL 3-arm NCT00622193

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Anamorelin HCl Dose Range Study to Evaluate the Safety and Efficacy of Anamorelin HCl in Patients With NSCLC

Sponsor: Helsinn Therapeutics (U.S.), Inc

Conditions Carcinoma, Non-Small-Cell Lung

Interventions anamorelin HCl placebo

Updated 9 times since 2017 Last updated: Apr 12, 2017 Started: Mar 31, 2008 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00622193, this PHASE2 trial focuses on Carcinoma, Non-Small-Cell Lung and remains completed. Sponsored by Helsinn Therapeutics (U.S.), Inc, it has been updated 9 times since 2008, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE2
Sep 2025 — Jan 2026 [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Jan 2021 — Apr 2022 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Helsinn Therapeutics (U.S.), Inc

Data source: Helsinn Therapeutics (U.S.), Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Augusta, United States , Baltimore, United States , Bhopal, India , Boston, United States , Chennai, India , Corinth, United States , Delhi, India , Durham, United States , Hilton Head Island, United States , Houston, United States and 16 more locations